eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Warner Chilcott UK Limited
1 The Heights, Brooklands, Weybridge, KT12 0NY
Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701
Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/11/2011
PIL Actonel Once a Week 35mg film coated tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 07/10/2010 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
Updated on 17/05/2010 and displayed until 07/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change of licence holder
Updated on 09/07/2009 and displayed until 17/05/2010
Reasons for adding or updating:
  • Change in co-marketing arrangement
Updated on 09/01/2009 and displayed until 09/07/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 15/09/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
Updated on 13/08/2008 and displayed until 15/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 15/02/2008 and displayed until 13/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/03/2005 and displayed until 15/02/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/03/2004 and displayed until 04/03/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
  • PIL Retired pending re-submission
Updated on 27/02/2004 and displayed until 08/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 03/02/2003 and displayed until 27/02/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  risedronate sodium